Dysphagia improvement · patients with dysphagia in oesophageal cancer
1 finding from 1 review
Persistent or recurrent dysphagia · patients with dysphagia in oesophageal cancer
SEMS showed no clear difference in persistent or recurrent dysphagia (analysis by concealment of… compared with plastic tube (degree of concealment) (high certainty).
3 findings from 1 review
OR 0.49 [0.19, 1.28]
4 studies · 323 participants
High
OR 0.29 [0.07, 1.21]
3 studies · 110 participants
High
OR 0.41 [0.2, 0.85]
7 studies · 433 participants
High
Subgroup analysis dysphagia improvement · patients with dysphagia in oesophageal cancer
1 finding from 1 review
All major side effects (analysis by concealment of allocation) ‐ Concealment of allocation A · patients with dysphagia in oesophageal cancer
SEMS probably leads to lower all major side effects (analysis by concealment of allocation) ‐… compared with plastic tube (degree of concealment) (moderate certainty).
1 finding from 1 review
All major side effects (analysis by concealment of allocation) ‐ Concealment of allocation non‐A · patients with dysphagia in oesophageal cancer
SEMS probably leads to lower all major side effects (analysis by concealment of allocation) ‐… compared with plastic tube (degree of concealment) (moderate certainty).
1 finding from 1 review
All major adverse effects · patients with dysphagia in oesophageal cancer
SEMS probably leads to lower all major adverse effects compared with plastic tube (main analysis) (moderate certainty).
1 finding from 1 review
Persistent or recurrent dysphagia · patients with dysphagia in oesophageal cancer
SEMS showed no clear difference in persistent or recurrent dysphagia compared with laser (high certainty).
1 finding from 1 review
Interventions for recurrent dysphagia · patients with dysphagia in oesophageal cancer
SEMS leads to lower interventions for recurrent dysphagia compared with laser (high certainty).
1 finding from 1 review
Adverse effects ‐ All adverse effects · patients with dysphagia in oesophageal cancer
SEMS showed no clear difference in adverse effects ‐ All adverse effects compared with laser (moderate certainty).
1 finding from 1 review
Dysphagia improvement · patients with dysphagia in oesophageal cancer
1 finding from 1 review
Persistent or recurrent dysphagia · patients with dysphagia in oesophageal cancer
Covered Ultraflex SEMS showed no clear difference in persistent or recurrent dysphagia compared with covered Wallstent (moderate certainty).
1 finding from 1 review
All adverse effects · patients with dysphagia in oesophageal cancer
Covered Ultraflex SEMS showed no clear difference in all adverse effects compared with covered Wallstent (moderate certainty).
1 finding from 1 review